A Study on TLC590 for Managing Postsurgical Pain — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study on TLC590 for Managing Postsurgical Pain — Stella

Home/Postsurgical Pain Management/

View on ClinicalTrials.gov

Recruiting

Back to Postsurgical Pain Management trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

First Surgical Hospital, Bellaire, Texas

Memorial Hermann Village, Houston, Texas

Key details

Phase

Safety & dosing

Sponsor

TLC Biopharmaceuticals, Inc.

Enrollment target

~120 participants

Started

September 2024

Primary completion

July 2026

Age range

18 Years – 70 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.